newsfilter
← Latest News
Business Wire·

TherapeuticsMD Completes the Divestiture of vitaCare Prescription Services to GoodRx in a Cash Transaction Valued at $150 Million

TherapeuticsMD, Inc. (NASDAQ:TXMD), ("TXMD" or the "Company") an innovative, leading women's healthcare company, announced today the closing of the divestiture of vitaCare Prescription Services to GoodRx (NASDAQ:GDRX), in a cash transaction valued at $1